TrialFrontiers in rehabilitation sciences2025
Efficacy of botulinum toxin type A in myogenic temporomandibulardisorders: a single arm, prospective, pilot study.
Bruno Macedo de Sousa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.